Literature DB >> 10925350

Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction.

H Tomoda1, N Aoki.   

Abstract

BACKGROUND: Inflammation is an important feature of atherosclerotic lesions, and the vulnerability of coronary lesions in acute myocardial infarction (AMI) at the time of onset may be related to blood levels of C-reactive protein (CRP) on admission, before CRP levels are affected by myocardial damage.
METHODS: A total of 234 patients with AMI in whom plasma CRP was measured within 6 hours after onset were studied. They were divided into 2 groups: group 1 (n = 49) with elevated CRP (>/=0.3 mg/dL) on admission within 6 hours after onset and group 2 (n = 185) with normal CRP (<0.3 mg/dL) within 6 hours after onset. All were treated by primary percutaneous transluminal coronary angioplasty with provisional stenting.
RESULTS: There were no significant differences in baseline characteristics between the 2 groups. In-hospital adverse coronary events, including coronary reocclusion, reinfarction, target vessel revascularization, and death, were significantly more frequent in group 1 (22.4%) than in group 2 (4.3%, P <.005), and bailout stenting was performed significantly more frequently in group 1 (61. 2%) than in group 2 (37.8%, P <.005). In contrast, there were no significant differences between the 2 groups in parameters that represent myocardial damage, including peak creatine kinase and left ventricular ejection fraction.
CONCLUSION: CRP levels within 6 hours after the onset of AMI reflect the vulnerability of culprit coronary lesions and predict adverse coronary events after primary PTCA/stenting.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10925350     DOI: 10.1067/mhj.2000.108244

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  21 in total

1.  Early detection of C-reactive protein and von Willebrand factor levels in Malaysian patients with acute coronary syndrome.

Authors:  Wen Ni Tiong; Edmund Ui Hang Sim; Alan Yean Yip Fong; Tiong Kiam Ong
Journal:  J Cardiovasc Dis Res       Date:  2013-02-27

2.  Role of pre-procedural C-reactive protein level in the prediction of major adverse cardiac events in patients undergoing percutaneous coronary intervention: a meta-analysisof longitudinal studies.

Authors:  Singh-Baniya Bibek; Yong Xie; Jia-Jia Gao; Zhi Wang; Jing-Feng Wang; Deng-Feng Geng
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

3.  Admission C-reactive protein and short- as well as long-term mortality in diabetic versus non-diabetic patients with incident myocardial infarction.

Authors:  C Meisinger; M Heier; W von Scheidt; B Kuch
Journal:  Clin Res Cardiol       Date:  2010-07-02       Impact factor: 5.460

Review 4.  Nonalcoholic fatty liver disease: implications for cardiovascular risk.

Authors:  Amreen Dinani; Arun Sanyal
Journal:  Cardiovasc Endocrinol       Date:  2017-05-17

5.  C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study.

Authors:  Eric S Williams; Sanjiv J Shah; Sadia Ali; Bee Ya Na; Nelson B Schiller; Mary A Whooley
Journal:  Eur J Heart Fail       Date:  2007-12-21       Impact factor: 15.534

6.  C-reactive protein activates complement in infarcted human myocardium.

Authors:  Remco Nijmeijer; Wim K Lagrand; Yvonne T P Lubbers; Cees A Visser; Chris J L M Meijer; Hans W M Niessen; C Erik Hack
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

Review 7.  CRP and the risk of atherosclerotic events.

Authors:  Paolo Calabrò; Enrica Golia; Edward T H Yeh
Journal:  Semin Immunopathol       Date:  2009-05-05       Impact factor: 9.623

8.  Association of Serum Total Bilirubin with Serum High Sensitivity C-reactive Protein in Middle-aged Men.

Authors:  Kiwoong Yu; Cheolhwan Kim; Eunju Sung; Hocheol Shin; Hyewon Lee
Journal:  Korean J Fam Med       Date:  2011-09-28

9.  Combined Assessments of Biochemical Markers and ST-Segment Resolution Provide Additional Prognostic Information for Patients With ST-Segment Elevation Myocardial Infarction.

Authors:  Jong Shin Woo; Jin Man Cho; Soo Joong Kim; Myeong Kon Kim; Chong Jin Kim
Journal:  Korean Circ J       Date:  2011-07-30       Impact factor: 3.243

10.  C-reactive Protein as a Predictor of Adverse outcome in Patients with Acute Coronary Syndrome.

Authors:  A S Sheikh; S Yahya; N S Sheikh; A A Sheikh
Journal:  Heart Views       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.